BECKMAN COULTER DIAGNOSTICS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2020–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	1	1
2021	—	5	1
2020	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BROWNSTEIN HYATT FARBER SCHRECK, LLP	—	10

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	7
SENATE	7
Health & Human Services, Dept of (HHS)	4
White House Office	2
Centers For Disease Control & Prevention (CDC)	1
Executive Office of the President (EOP)	1
Office of the Vice President of the United States	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	8
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	3

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1319117th Congress

American Rescue Plan Act of 2021

Cited source text and reported amounts

Issues related to COVID-19 H.R.1319 - American Rescue Plan Act of 2021

Client expense: — · Firm income: $90,000

Matched citations: H.R.1319

H.R. 1319117th Congress

American Rescue Plan Act of 2021

Cited source text and reported amounts

Issues related to COVID-19 H.R.1319 - American Rescue Plan Act of 2021

Client expense: — · Firm income: $90,000

Matched citations: H.R.1319

H.R. 133116th Congress

Consolidated Appropriations Act, 2021

Cited source text and reported amounts

Issues related to COVID-19; H.R. 133 Consolidated Appropriations Act, 2021

Client expense: — · Firm income: $90,000

Matched citations: H.R. 133

BECKMAN COULTER DIAGNOSTICS — Lobbying Disclosure | Poliscope